In the present study, we reported that the expression of SPNS2 in CRC specimens was lower than in its precursor lesion colon adenoma. And its low expression was associated with poor differentiation, advanced TNM stage and poor prognosis in CRC. This evidence concerns the gene SPNS2 and colorectal carcinoma.